The Drug Delivery Special Interest Group will deal with the science and technology of controlled release of active agents from delivery systems. Controlled drug release is achieved by the use of diffusion, chemical reactions, dissolutions or osmosis, used either singly or in combination. While the vast majority of such delivery devices are based on polymers, controlled release can also be achieved by the use of mechanical pumps. In a broader sense, controlled release also involves control over the site of action of the active agent, using the active agent using pro-drugs, targetable water soluble polymers or various microparticulate systems. Relevant aspects of toxicology, bioavailability, pharmacokinetics, and biocompatibility are also included.

Chair: Mark Byrne, PhD
Auburn University
Dept of Chemical Engineering
230 Ross Hall
Auburn, AL  36849-5127
t: (334) 844-2862
f: (334) 844-2063
e: byrneme@eng.auburn.edu

Vice-Chair: Liisa Kuhn, PhD
University of Connecticut Health Center
Center for Biomaterials
263 Farmington Avenue
Farmington, CT  06030-1715
t:  (860) 679-3922
f:  (860) 679-2910
e:  lkuhn@uchc.edu

Secretary/Treasurer: J. Zach Hilt, PhD
University of Kentucky
Dept of Chemical & Materials Engineering
177 F. Paul Anderson Tower
Lexington, KY  40506
t: (859) 257-9844
f: (859) 323-1929
e: hilt@engr.uky.edu

Program Chair: Richard A. Gemeinhart, PhD
University of Illinois
Dept of Biopharmaceutical Sciences
833 S Wood St
MC 865
Chicago, IL  60612-7231
t: (312) 996-2253
f: (312) 996-2784
e: rag@uic.edu